Immunomodulatory effects of Aureobasidium pullulans SM-2001 exopolymers on cyclophosphamide-treated mice

Journal of Microbiology and Biotechnology

Volumn 20, Issue 2, 2010, Pages 433-450

  Yoon, Hyun Soo ^a   Kim, Joo Wan ^b   Cho, Hyung Rae ^b   Moon, Seung Bae ^b   Shin, Hyun Dong ^c   Yang, Kun Ju ^b   Lee, Hyeung Sik ^d   Kwon, Young Sam ^e   Ku, Sae Kwang ^d  

^a Hanyang University College of Medicine   (South Korea)

^b Glucan Corporation   (South Korea)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^d Daegu Haany University   (South Korea)

^e Kyungpook National University   (South Korea)

Author keywords

Aureobasidium pullulans SM 2001; Cyclophosphamide; Exopolymers; Immunomodulatory effects; Mouse; glucan

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; SM 2001; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AUREOBASIDIUM PULLULANS; CONTROLLED STUDY; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; SPLEEN CELL; T LYMPHOCYTE; THYMOCYTE;

AUREOBASIDIUM PULLULANS; MUS;

EID: 77649214918     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.0905.05058     Document Type: Article

References (39)

1. + cells in the spleen of cyclophosphamide-treated mice: Implications for T-cell responses in immunosuppressed mice. Blood 95: 212-220.
2. Benach, J. L., G. S. Habicht, T. W. Holbrook, and J. A. Cook. 1982. Glucan as an adjuvant for a murine Babesia microti immunization trial. Infect. Immun. 35: 947-951.
3. Browder, I. W., D. L. Williams, A. Kitahama, and N. R. Di Luzio. 1984. Modification of post-operative C. albicans sepsis by glucan immunostimulation. Int. J. Immunopharmacol. 6: 19-26.
4. Burnet, M. 1995. The helper T-cell responses, pp. 139-154. In I. R. Tizard (ed.). Immunology, an Introduction, 4th Ed. Saunders, Philadelphia.
5. Chirigos, M. A., W. A. Stylos, R. M. Schultz, and J. R. Fullen. 1978. Chemical and biological adjuvants capable of potentiating tumor cell vaccine. Cancer Res. 38: 1085-1091.
6. Clark, B. D., I. Bedrosian, R. Schindler, F. Cominelli, J. G. Cannon, A. R. Shaw, and C. A. Dinarello. 1991. Detection of interleukin 1 alpha and 1 beta in rabbit tissues during endotoxemia using sensitive radioimmunoassays. J. Appl. Physiol. 71: 2412-2418.
7. Di Luzio, N. R., D. L. Williams, R. B. McNamee, B. F. Edwards, and A. Kitahama. 1979. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Int. J. Cancer 24: 773-779.
8. Di Luzio, N. R. and D. L. Williams. 1978. Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice. Infect. Immun. 20: 804-810.
9. El-Bayoumy, K. 2001. The protective role of selenium on genetic damage and on cancer. Mutat. Res. 475: 123-139.
10. Estrada, A., C. H. Yun, A. Van Kessel, B. Li, S. Hauta, and B. Laarveld. 1997. Immunomodulatory activities of oat beta-glucan in vitro and in vivo. Microbiol. Immunol. 41: 991-998.
11. Grochow, L. B. 1996. Covalent DNA-binding drugs, pp. 293-316. In M. C. Perry (ed.). The Chemotherapy Source Book. Williams & Wilkins, Baltimore.
12. Guillaume, T., D. B. Rubinstein, and M. Symann. 1998. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 92: 1471-1490.
13. Hofer, M. and M. Pospisil. 1997. Glucan as stimulator of hematopoiesis in normal and gamma-irradiated mice. A survey of the authors' results. Int. J. Immunopharmacol. 19: 607-609.
14. Holbrook, T. W., J. A. Cook, and B. W. Parker. 1981. Immunization against Leishmania donovani: Glucan as an adjuvant with killed promastigotes. Am. J. Trop. Med. Hyg. 30: 762-768.
15. Hosseinimehr, S. J. and M. Karami. 2005. Citrus extract modulates genotoxicity induced by cyclophosphamide in mice bone marrow cells. J. Pharm. Pharmacol. 57: 505-509.
16. Hotchkiss, R. S., D. F. Osborne, G. D. Lappas, and I. E. Karl. 1995. Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 alpha in a mouse model of endotoxin. Shock 3: 337-342.
17. Hoyert, D. L., K. D. Kochanek, and S. L. Murphy. 1999. Deaths: Final data for 1997. Natl. Vital. Stat. Rep. 47: 1-104.
18. Hu, Q., J. Xu, and L. Chen. 2005. Antimutagenicity of selenium-enriched rice on mice exposure to cyclophosphamide and mitomycin C. Cancer Lett. 220: 29-35.
19. Isaacs, A. 1995. Lymphokines and cytokines, pp. 155-169. In I. R. Tizard (ed.). Immunology, an Introduction, 4th Ed. Saunders, Philadelphia.
20. Kim, H. D., H. R. Cho, S. B. Moon, H. D. Shin, K. J. Yang, B. R. Park, et al. 2006. Effect of exopolymers from Aureobasidium pullulans on formalin-induced chronic paw inflammation in mice. J. Microbiol. Biotechnol. 16: 1954-1960.
21. Kim, H. D., H. R. Cho, S. B. Moon, H. D. Shin, K. J. Yang, B. R. Park, et al. 2008. Effects of β-glucan from Aureobasidium pullulans on acute inflammation in mice. Arch. Pharm. Res. 30: 323-328.
22. Lee, H. S., H. R. Cho, S. B. Moon, H. D. Shin, K. J. Yang, B. R. Park, H. J. Jang, L. S. Kim, and S. K. Ku. 2008. Effect of β-glucan from Aureobasidium pullulans on rat rib fracture healing. Lab. Anim. Res. 24: 39-44.
23. Lee, J. N., D. Y. Lee, I. H. Ji, G. E. Kim, H. N. Kim, J. Sohn, S. Kim, and C. W. Kim. 2001. Purification of soluble beta-glucan with immune-enhancing activity from the cell wall of yeast. Biosci. Biotechnol. Biochem. 65: 837-841.
24. Lotzova, E. and J. U. Gutterman. 1979. Effect of glucan on natural killer (NK) cells: Further comparison between NK cell and bone marrow effector cell activities. J. Immunol. 123: 607-611.
25. Mackin, W. M., D. Brunke-Reese, Y. Gu, C. Crotty, and L. Fisette. 1994. Enhanced microbial activities of human peripheral blood monocytes and neutrophils (PMN) after pre-treatment with PGG-glucan (Betafectin™). FASEB J. 8: A216.
26. Masihi, K. N., K. Madaj, H. Hintelmann, G. Gast, and Y. Kaneko. 1997. Down-regulation of tumor necrosis factor-α, moderate reduction of interleukin-1β, but not interleukin-6 or interleukin-10, by glucan immunomodulators curdlan sulfate and lentinan. Int. J. Immunopharmacol. 19: 463-468.
27. Miyauchi, A., C. Hiramine, S. Tanaka, and K. Hojo. 1990. Differential effects of a single dose of cyclophosphamide on T cell subsets of the thymus and spleen in mice: Flow cytofluorometry analysis. Tohoku J. Exp. Med. 162: 147-167.
28. Parkman, R. and K. I. Weinberg. 1997. Immunological reconstitution following bone marrow transplantation. Immunol. Rev. 157: 73-78.
29. Pileri, S. A., G. Roncador, C. Ceccarelli, M. Piccioli, A. Briskomatis, E. Sabattini, et al. 1997. Antigen retrieval techniques in immunohistochemistry: Comparison of different methods. J. Pathol. 183: 116-123.
30. Poutsiaka, D. D., M. Mengozzi, E. Vannier, B. Sinha, and C. A. Dinarello. 1993. Cross-linking of the beta-glucan receptor on human monocytes results in interleukin-1 receptor antagonist but not interleukin-1 production. Blood 82: 3695-3700.
31. Samira, S., C. Ferrand, A. Peled, A. Nagler, Y. Tovbin, H. Ben-Hur, N. Taylor, A. Globerson, and T. Lapidot. 2004. Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice. Stem Cells 22: 1085-1100.
32. Seo, H. P., J. M. Kim, H. D. Shin, T. K. Kim, H. J. Chang, B. R. Park, and J. W. Lee. 2002. Production of -1,3/1,6-glucan by Aureobasidium pullulans SM-2001. Korean J. Biotechnol. Bioeng. 17: 376-380.
33. Shi, S. R., B. Chaiwun, L. Young, R. J. Cote, and C. R. Taylor. 1993. Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J. Histochem. Cytochem. 41: 1599-1604.
34. Shin, H. D., K. J. Yang, B. R. Park, C. W. Son, H. J. Jang, and S. K. Ku. 2007. Antiosteoporotic effect of Polycan, beta-glucan from Aureobasidium, in ovariectomized osteoporotic mice. Nutrition 23: 853-860.
35. Soltys, J. and M. T. Quinn. 1999. Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan. Infect. Immun. 67: 244-252.
36. Tzianabos, A. O. 2000. Polysaccharide immunomodulators as therapeutic agents: Structural aspects and biologic function. Clin. Microbiol. Rev. 13: 523-533.
37. Unanue, E. R. 1995. The mononuclear-phagocytic system, pp. 61-74. In I. R. Tizard (ed.). Immunology, an Introduction, 4th Ed. Saunders, Philadelphia.
38. Xun, C. Q., J. S. Thompson, C. D. Jennings, S. A. Brown, and M. B. Widmer. 1994. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood 83: 2360-2367.
39. Yan, J. J., J. S. Jung, J. E. Lee, J. Lee, S. O. Huh, H. S. Kim, et al. 2004. Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat. Med. 10: 161-167.